Date: 2024/12/11 - 21:32
New research from RVO Health found that a quitline-based program led to vaping cessation in 45% of young adults. The quitline intervention that included nicotine replacement therapy (NRT) seemed most promising. This is the first randomized trial testing NRT for vaping cessation.
Date: 2024/12/06 - 00:00
Drug manufacturer Eli Lilly says their drug Zepbound is more effective than Wegovy for long-term weight loss. Results from a clinical trial show 20% of participants who took Zepbound achieved significant weight loss compared to nearly 14% of participants who took Wegovy.